business Wire requests that the press release NewsItemId: 20220929005273 "Cerebain Biotech Has Made a Capital Investment in Diabetes Reversal Group, LLC" be removed.
Business Wire
888-381-9473
business Wire requests that the press release NewsItemId: 20220929005273 "Cerebain Biotech Has Made a Capital Investment in Diabetes Reversal Group, LLC" be removed.
Business Wire
888-381-9473
Market Wire News is a media platform, the information on this page was provided by Business Wire via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Cerebain Biotech Corp Com Company Name:
CBBT Stock Symbol:
Market:
Business Wire requests that the press release NewsItemId: 20220929005273 "Cerebain Biotech Has Made a Capital Investment in Diabetes Reversal Group, LLC" be removed. Business Wire 888-381-9473
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has made a capital investment in Diabetes Reversal Group, LLC. “Cerebain is happy to announce it has made a capital investment in Diabetes Reversal Group, LLC...
Cerebain Biotech Corp. (OTC: CBBT), (the “Company” or “Cerebain”) today announced that it has closed the Share Exchange Agreement with PKG, Inc. (PKG) thereby having total control and ownership of PKG, Inc. About Cerebain Biotech Corp. Cerebain Bi...